Soil partice-size distribution. by Yonggang Huang (223155)

“…When the length of UHMWPE is greater than 9 mm, there is no significant decrease in the free swelling ratio of the reinforced soil (<i>p</i> = 0.165). …”

Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. by Farrokh Habibzadeh (12256529)

Subjects:

Statins resulted in smaller neuronal soma size. by Shuk C. Tsoi (21192243)

“…Statin treatment decreased cell sizes in the larger cells more than in the smaller cells as seen in the greater divergence between lines plotted for larger cell somas (bottom panel). …”

Selection of final barriers based on significance. by Hasan Shahriar (5015273)

Subjects:

Pairwise comparison matrix of barriers’ significance. by Hasan Shahriar (5015273)

Subjects:

Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. by Xiang-Fan Chen (13932983)

Schematic diagram of experimental injector size. by Lei Bai (631944)

Subjects:

Analysis of Significantly Different Bacteria. by Xu Jia (187142)

Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

The variables that significantly predicted litter clump weight in shelter cats. by Allison Andrukonis (11846404)

Linguistic terms and corresponding triangular fuzzy scale for barrier significance assessment. by Hasan Shahriar (5015273)

Subjects:

Barriers to medication adherence. by Shiva Mohammadi (20227740)

Subjects:

Sobel test for the significance of the mediation effect. by Getachew Magnar Kitila (19935139)

Significant condition. by Junxia Zhou (14381598)

Subjects:

Location, timing, and size of the European outbreaks. by Albertus Constantijn Sloof (20405090)

Barriers to DA. by Elizabeth Noble (4113616)

Subjects:

Significant cholesterol genes arranged by day. by Katherine M. Peterson (19746455)

Sample size and span size diagram. by Wen Wang (6570)

Bioengineering Approaches for the 3D Blood–Retinal Barrier: Disease Modeling and Drug Development by Ruiyi Yan (4594162)

“…In order to understand and recapitulate various retinal diseases, there has been significant interest in the progress of in vitro 3D-BRB models as they may address limitations associated with traditional 2D cultures and xenogeneic animal models. …”